Thanks for the replies. I actually work in the mental health field and am in school to advance. Psychopharmacology is my area of "pseudo-specialty" and interest.
I dont really like the diagnosis of rapid cycling bipolar in this case. She really presents with Borderline Personality Disorder traits secondary to PTSD; and rapid (like daily) mood swings without periods of extreme mania are actually associated with both PTSD and Borderline PD. End result is the same I suppose, medication wise.
I think I'm feeling fear that "psychoticism" is beginning to present but it's not like full blown psychosis; it's like paranoia and thinking I'm talking behind her back, little paranoid ideations like that. Not these elaborate psychotic worlds I have heard while working in inpatient units.
He is starting her on vraylar to reduce this bit paranoid ideation, which makes sense.
I take rexulti in the evening and ironically vyvanse and adderall during the day. I used to be on seroquel and I can say that I personally like the 3rd gen APs best. I have persistent depressive disorder/dysthymia (treatment resistant) and severe anxiety w/panic disorder.
On a personal note, I am struggling greatly with all of this and it's getting hard to keep getting up every day.
To Kush:
Yes, antipsychotics come in what they call 1st generation, 2nd generation, and now 3rd generation. They all hold similar properties and primarily act on the Dopamine and Serotonin receptors as antagonists or mixed/partial agonists. They vary in their binding affinities and target sites giving them slightly different qualities. The older ones (including gen 2) tend to be pretty heavy antihistamines as well, especially at lower doses (like 25mg seroquel). I'm sure someone with more knowledge can jump in.
1st gen are haldol, thorazine etc
2nd gen seroquel (quetiapine) zyprexa (olanzapine)
3rd gen rexulti, vraylar
The 2nd and 3rd generation APs are supposed to have less effect on the pyramidal motor pathways I believe, which makes them less likely to produce muscle movement disorders.